Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

Summary

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in adolescents with obesity.

Timeline

Start

2025-04-10

Primary completion

2028-01-01

Completion

2028-02-01

Drugs

Indications